Perspectum Diagnostics Ltd, Oxford, United Kingdom.
Department of Life Sciences, University of Westminster, London, United Kingdom.
PLoS One. 2019 Apr 10;14(4):e0214921. doi: 10.1371/journal.pone.0214921. eCollection 2019.
As the burden of liver disease reaches epidemic levels, there is a high unmet medical need to develop robust, accurate and reproducible non-invasive methods to quantify liver tissue characteristics for use in clinical development and ultimately in clinical practice. This prospective cross-sectional study systematically examines the repeatability and reproducibility of iron-corrected T1 (cT1), T2*, and hepatic proton density fat fraction (PDFF) quantification with multiparametric MRI across different field strengths, scanner manufacturers and models. 61 adult participants with mixed liver disease aetiology and those without any history of liver disease underwent multiparametric MRI on combinations of 5 scanner models from two manufacturers (Siemens and Philips) at different field strengths (1.5T and 3T). We report high repeatability and reproducibility across different field strengths, manufacturers, and scanner models in standardized cT1 (repeatability CoV: 1.7%, bias -7.5ms, 95% LoA of -53.6 ms to 38.5 ms; reproducibility CoV 3.3%, bias 6.5 ms, 95% LoA of -76.3 to 89.2 ms) and T2* (repeatability CoV: 5.5%, bias -0.18 ms, 95% LoA -5.41 to 5.05 ms; reproducibility CoV 6.6%, bias -1.7 ms, 95% LoA -6.61 to 3.15 ms) in human measurements. PDFF repeatability (0.8%) and reproducibility (0.75%) coefficients showed high precision of this metric. Similar precision was observed in phantom measurements. Inspection of the ICC model indicated that most of the variance in cT1 could be accounted for by study participants (ICC = 0.91), with minimal contribution from technical differences. We demonstrate that multiparametric MRI is a non-invasive, repeatable and reproducible method for quantifying liver tissue characteristics across manufacturers (Philips and Siemens) and field strengths (1.5T and 3T).
随着肝病负担达到流行水平,开发强大、准确和可重复的非侵入性方法来量化肝脏组织特征以用于临床开发并最终用于临床实践的需求非常高。这项前瞻性横断面研究系统地检查了不同场强、扫描仪制造商和型号的多参数 MRI 中铁校正 T1(cT1)、T2和肝质子密度脂肪分数(PDFF)定量的可重复性和再现性。61 名患有混合肝病病因的成年参与者和无任何肝病病史的参与者在来自两个制造商(西门子和飞利浦)的 5 种不同型号的扫描仪上进行了多参数 MRI,场强分别为 1.5T 和 3T。我们报告了在不同场强、制造商和扫描仪模型中,标准化 cT1 的高可重复性和再现性(重复性 CoV:1.7%,偏倚-7.5ms,95% LoA-53.6ms 至 38.5ms;再现性 CoV 3.3%,偏倚 6.5ms,95% LoA-76.3ms 至 89.2ms)和 T2(重复性 CoV:5.5%,偏倚-0.18ms,95% LoA-5.41ms 至 5.05ms;再现性 CoV 6.6%,偏倚-1.7ms,95% LoA-6.61ms 至 3.15ms)在人体测量中的高重复性和再现性。PDFF 的重复性(0.8%)和再现性(0.75%)系数显示了该指标的高精度。在体模测量中也观察到了类似的精度。对 ICC 模型的检查表明,cT1 的大部分方差可以归因于研究参与者(ICC=0.91),而技术差异的贡献最小。我们证明,多参数 MRI 是一种非侵入性、可重复和可再现的方法,可用于量化不同制造商(飞利浦和西门子)和场强(1.5T 和 3T)的肝脏组织特征。